Medical Data Hypothesis Testing
ğŸ“ Project Overview
This project applies statistical hypothesis testing to a real-world medical dataset of breast cancer patients. The dataset includes patient demographics, biomarker levels, tumour stages, receptor statuses and surgical treatments.
The main objective is to test whether key clinical factors (such as tumour stage) are statistically associated with treatment decisions and patient outcomes.
ğŸ§© Methodology
1.	Data Cleaning (Python)
â¦	Loaded the raw dataset in Python (pandas).
â¦	Normalised column names (removed spaces, replaced with underscores).
â¦	Checked and handled missing values.
â¦	Converted categorical variables to consistent formats.
2.	Hypothesis Testing (Google Colab)
â¦	Used cross-tabulation and Chi-square tests to evaluate associations between:
â¦	Tumour Stage â†” Surgery Type
â¦	Tumour Stage â†” Patient Status
â¦	Checked normality of numeric variables (Age, Protein1â€“4) with histograms, Qâ€“Q plots and Shapiroâ€“Wilk tests.
â¦	Applied the correct test depending on variable types (categorical vs. numerical).
3.	Visualisation & Reporting
â¦	Created grouped bar charts for surgery type by tumour stage.
â¦	Produced Qâ€“Q plots for numeric variables.
â¦	Summarised p-values and statistical decisions in a results table.
ğŸ“Š Key Findings
â¦	Tumour stage and surgery type:
Chi-square test showed a statistically significant association (p < 0.05). Later stages were more likely to undergo more radical surgery types.
â¦	Tumour stage and patient status:
Chi-square test also showed a significant association (p < 0.05). Higher tumour stages corresponded to worse patient outcomes at last follow-up.
â¦	Normality checks:
Protein biomarkers were not perfectly normal; Age was approximately normal. This informed which tests (parametric vs. non-parametric) to use.
ğŸ’¡ Recommendations
â¦	Clinical planning: Findings support stage-based surgical decision-making and can inform resource allocation for more complex surgeries at later stages.
â¦	Data collection: Future datasets should include treatment follow-up times and additional biomarkers to strengthen survival analysis.
â¦	Statistical approach: Non-normal biomarker distributions suggest using non-parametric or transformed data for more accurate inference.
â¦	Next steps: Extend analysis to survival curves (Kaplanâ€“Meier) and logistic regression to model patient outcomes.
